Literature DB >> 3341620

Prevention of nosocomial pneumonia using topical and parenteral antimicrobial agents.

W G Johanson1, J J Seidenfeld, R de los Santos, J J Coalson, P Gomez.   

Abstract

The efficacy of antimicrobial agents applied topically in the oropharynx and trachea with and without intravenous antibiotics in preventing bacterial pneumonias during prolonged (7 to 10 days) mechanical ventilation was studied in 35 baboons, 30 of which had acute lung injury induced by either oleic acid or hyperoxia. In 12 animals receiving no antibiotics, only topical application of polymyxin B (PB), or only intravenous penicillin and gentamicin (IV PCN/GM), moderate or severe pneumonia was found in 81% of lobes examined at necropsy; no lobes were sterile. Pneumonias were polymicrobial in the absence of antibiotics, due to PCN-sensitive organisms in the topical PB group, and due to gram-negative bacilli in the IV PCN/GM group. Combinations of topical PB or GM or both plus IV PCN were highly efficacious in preventing pneumonia in 23 animals as only 15% of the lobes contained moderate to severe pneumonia and 52% of lobes were sterile. In these groups, histologically evident pneumonias were associated with low concentrations of bacteria in lung tissue, principally gram-negative bacilli resistant to the topical agent being used. Resistance to PB appeared to be solely due to selection of intrinsically resistant species, whereas resistance to GM may have developed through additional mechanisms as well. Although this approach to pneumonia prevention is clearly efficacious in this animal model, clinical studies are needed to define the frequency and significance of microbial resistance in human subjects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341620     DOI: 10.1164/ajrccm/137.2.265

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  18 in total

1.  Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailability.

Authors:  F Bressolle; J E de la Coussaye; R Ayoub; D Fabre; R Gomeni; G Saissi; J J Eledjam; M Galtier
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 2.  The adult respiratory distress syndrome. New insights into diagnosis, pathophysiology, and treatment.

Authors:  M A Matthay
Journal:  West J Med       Date:  1989-02

3.  Selective decontamination of the digestive tract: effect of cessation of routine application at an ICU.

Authors:  H A Tissot van Patot; J A Leusink; J Roodenburg; B M de Jongh; H S Lau; S de Boer; A de Boer
Journal:  Pharm World Sci       Date:  1996-10

4.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 5.  Systemic and endotracheal antibiotic prophylaxis of nosocomial pneumonia in ICU.

Authors:  H Lode; G Höffken; B Kemmerich; T Schaberg
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

6.  Natural history of dental plaque accumulation in mechanically ventilated adults: a descriptive correlational study.

Authors:  Deborah J Jones; Cindy L Munro; Mary Jo Grap
Journal:  Intensive Crit Care Nurs       Date:  2011-10-19       Impact factor: 3.072

7.  Infection prevention by selective decontamination in intensive care.

Authors:  W G Johanson
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

8.  Pneumonia prevention: a step backwards.

Authors:  W G Johanson
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

9.  Elastase activity in bronchoalveolar lavage fluid from oxygen-exposed, Pseudomonas-infected baboons.

Authors:  J F Collins; A A Anzueto; J I Peters; R de los Santos; D C Gonzalez; W G Johanson; J J Seidenfeld; J J Coalson; S G Jenkinson
Journal:  Lung       Date:  1991       Impact factor: 2.584

10.  Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study.

Authors:  J J Rouby; P Poète; E Martin de Lassale; M H Nicolas; L Bodin; V Jarlier; A M Korinek; P Viars
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.